Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: The M. D. Anderson experience

Guillermo Lazo, Hagop Kantarjian, Elihu Estey, Deborah Thomas, Susan O'Brien, Jorge Cortes

Research output: Contribution to journalArticlepeer-review

104 Scopus citations

Fingerprint

Dive into the research topics of 'Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: The M. D. Anderson experience'. Together they form a unique fingerprint.

Medicine & Life Sciences